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Dendritic cells (DC) are among the first targets of human immunodeficiency virus type-1 (HIV-1) infection and in turn play a crucial role in
viral transmission to T cells and in the regulation of the immune response. The major group of HIV-1 has diversified genetically based on variation
in env sequences and comprise at least 11 subtypes. Because little is known about the host response elicited against different HIV-1 clade isolates
in vivo, we sought to use gene expression profiling to identify genes regulated by HIV-1 subtypes B, C, and A/E upon de novo infection of
primary immature monocyte-derived DC (iMDDCs). A total of 3700 immune-related genes were subjected to a significance analysis of
microarrays (SAM); 656 genes were selected as significant and were further divided into 8 functional categories. Regardless of the time of
infection, 20% of the genes affected by HIV-1 were involved in signal transduction, followed by 14% of the genes identified as transcription-
related genes, and 7% were classified as playing a role in cell proliferation and cell cycle. Furthermore, 7% of the genes were immune response
genes. By 72 h postinfection, genes upregulated by subtype B included the inhibitor of the matrix metalloproteinase TIMP2 and the heat shock
protein 40 homolog (Hsp40) DNAJB1, whereas the IFN inducible gene STAT1, the MAPK1/ERK2 kinase regulator ST5, and the chemokine
CXCL3 and SHC1 genes were induced by subtypes C and A/E. These analyses distinguish a temporally regulated host response to de novo HIV-1
infection in primary dendritic cells.
© 2006 Elsevier Inc. All rights reserved.Keywords: HIV-1; Gene expression; Microarray; Immune response; Dendritic cellsIntroduction
The human immunodeficiency virus type-1 (HIV-1) is
responsible for the most devastating pandemic of the 20th and
21st centuries, affecting over 45 million individuals worldwide.
HIV-1 is classified into three groups that have developed across
the globe: M (major), O (outlying), and N (new). The M group
comprises at least 11 distinct subtypes or clades and at least 16
circulating recombinants forms (CRFs) including A–D, A/E,
A/G, F–H, J, and K forms, which are divided according to their
env genomic sequences. Within one subtype, the env variations
can reach up to 10–15%, whereas variation between subtypes
ranges from 20% to 30% (Gao et al., 1994, 1998a, 1998b;⁎ Corresponding author. Fax: +1 514 340 7576.
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et al., 2000, 2001). The demographic distribution of the
different subtypes varies significantly; subtype B predominates
in North America and Europe; subtype C is mainly found in
sub-Saharan Africa; and the recombinant form A/E subtype is
predominantly detected in Southeast Asia. Furthermore,
analysis of the current worldwide distribution of HIV-1
subtypes has concluded that HIV-C and HIV-A/E are the most
prevalent HIV subtypes in the world, since these subtypes are
expanding faster and are infecting a large proportion of the
population, especially in areas where the pandemic is
uncontrolled (Burke and McCutchan, 1996; Montano et al.,
1997; Spira et al., 2003).
It remains unclear whether the HIV-1 subtypes have different
biological properties that lead to differences in disease prog-
ression, transmission efficiency, and dissemination (Kaleebu et
87M. Solis et al. / Virology 352 (2006) 86–99al., 2001; Kanki et al., 1999; van Opijnen et al., 2004); some
groups have suggested that subtype E viruses exhibit high
replication rates and enhanced virulence in Langerhans cells
(Soto-Ramirez et al., 1996), whereas others have stated that there
was no discernible differences between the ability of different
HIV-1 subtypes to replicate in these skin-derived dendritic cells
(DCs) (Pope et al., 1997).
Dendritic cells are professional antigen presenting cells
(APCs) that perform an essential role in the induction and
regulation of adaptive immune responses (Banchereau and
Steinman, 1998). Antigen uptake by immature DCs (iDCs)
induces maturation and migration of iDCs to the lymph nodes,
where antigen is presented to naive CD4+ and CD8+ T cells
resulting in T cells priming and activation of specific immune
responses against the invading pathogens. However, DCs also
play a major role in the propagation of HIV-1, since dendritic
cell lineages, including Langerhans cells or DCs from lymphoid
tissues (e.g., tonsils, adenoids, lymph nodes, Peyer's patches),
are among the first targets of HIV-1 infection after the virus has
crossed the mucosal barrier (Bakri et al., 2001; Masurier et al.,
1998). Studies have suggested that upon virus encounter, very
few DCs are required to propagate large amounts of virus in the
cellular environment upon CD4+ T cell interaction in vitro
(Pope et al., 1995), thus reflecting the importance of studying
the interaction between HIV-1 and DCs in the early phase of
infection.
DCs are known to express the principal HIV-1 receptors and
coreceptors CD4, CCR5, and CXCR4 and a C-type lectin re-
ceptor DC-SIGN (CD209). Immature DCs in particular express
CCR5 and thus selectively replicate R5-tropic virus strains
(Wilflingseder et al., 2005), whereas mature DCs are less
susceptible to HIV-1 infection because of a lower expression of
CCR5. Nevertheless, mature DCs can capture R5- or X4-tropic
viruses by DC-SIGN, store the virus in intracellular compart-
ments in the absence of viral replication, and later transfer the
virus to CD4+ T cells by a mechanism called trans-infection
(Arrighi et al., 2004; Geijtenbeek et al., 2000; Pohlmann et al.,
2001). Unfortunately, little is known about the pathways pre-
ferentially utilized by HIV-1 to initiate DC infection. Because
many studies have demonstrated that myeloid DCs are sus-
ceptible to HIV-1 infection in vitro, we used transcriptional
profiling by microarray to monitor differences in the gene ex-
pression profile of primary immature monocyte-derived den-
dritic cells following de novo infection by different HIV-1 clade
viruses. Immaturemonocyte-derived DCs obtained from healthy
donors were infected with different HIV-1 subtypes B, C, and
A/E and global responses were measured at different times.
Here, we report the kinetics of the dendritic cell response to HIV-
1 infection.
Results
Kinetics of HIV-1 clades B, C, and A/E replication in immature
DCs
DCs were prepared from cultures of monocytes from peri-
pheral blood of four healthy donors. To ensure high cell purity,we depleted CD3+ lymphocytes from whole blood before iso-
lating using CD14+ monocytes by positive selection magnetic
cell sorting. Flow cytometry analysis of the monocyte
population showed cell purity superior to 98%, in the absence
of CD3+ T and CD19+ B lymphocytes. Monocytes were
differentiated into immature DCs for 6 days in medium
supplemented with IL-4 and GM-CSF. Immature DCs were
CD14−, HLA-DR+, CD83−, and a high fraction of these cells
were CD1a+. Most immature cells expressed high levels of DC-
SIGN and CCR5 (data not shown), whereas a smaller fraction
expressed detectable levels of CD4. Expression of HLA-DR,
CD80, and CD83 was upregulated after maturation induced with
LPS (Fig. 1), whereas the levels of DC-SIGN and CD4 remained
unchanged (data not shown). In HIV-1-infected DCs, levels of
HLA-DR, CD80, DC-SIGN, and CD4 remained unchanged
compared to uninfected DCs.
The kinetics of HIV-1 clade B, C, or A/E replication was
initially investigated; immature DCs were exposed for 2 h at
an MOI 0.1 to primary isolates of HIV-1 clades B, C, and A/
E, all of which are R5-tropic strains that use the CCR5
coreceptor for entry into DCs or macrophages. Data for a
representative donor (donor #152, Fig. 2) as well as others
(data not shown) showed that p24 antigen was detected as
early as 2 h after infection. The levels of p24 Gag antigen
reached a plateau before 24 h postinfection, but the levels
were variable between clades. In particular, infection of DCs
with HIV-1 subtype B yielded 3 to 4 times higher levels of
p24 in supernatants compared to subtypes C or A/E. This
result demonstrated that immature DCs were permissive to
HIV entry and replication, as previously reported, and
suggested that infection with subtype B resulted in higher
viral replication compared to subtype C or A/E, perhaps due
to increased viral replication in each dendritic cell or
alternatively to more efficient viral binding and entry with
subtype B.
Specificity of gene expression changes induced by HIV-1
subtypes B, C, and A/E
To accurately analyze changes in host gene expression
induced by subtypes B, C and A/E of HIV-1, respectively, we
compared uninfected cells with the population of HIV-1-
infected cells. For this purpose, immature MDDCs from four
donors were either incubated with the three subtypes,
respectively, for 2, 6, 24 and 72 h since these times reflected
HIV-1 entry and initiation of replication, based on the kinetics
of p24 supernatant levels. A total of 48 RNA samples from
each time point were converted into dye-labeled cDNA and
probes were then hybridized to human ImmuneArray cDNA
arrays (UHN Microarray Center, University of Toronto). For
each time point, the uninfected sample was subtracted from
each infected sample. ANOVA analysis of 3700 genes was
then performed.
The ANOVA analysis selected 64 genes (P < 0.05) that
displayed differential gene expression depending on the HIV-1
subtype. The ANOVA and PCA analyses showed that no
clade-specific gene profile was detectable during the first 24
Fig. 1. Characterization of MDDC.Monocytes were differentiated into immature MDDC for 6 days in the presence of IL-4 and GM-CSF. The cell profile was analyzed
by flow cytometry for the expression of CD14, HLA-DR, CD1a, CD80, and CD83 on immature versus mature MDDC [i.e., activated with LPS (1 μg/ml) for 2 days]
and also for the expression of CD4, DC-SIGN, HLA-DR, and CD80 in HIV-infected DCs versus uninfected.
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course (72 h; Fig. 3), in which differentiation between
subtypes was mainly observed. By 72 h postinfection, the
subtype B gene expression profile was slightly different from
the profiles obtained with clade C or A/E, based on the
comparison of 64 genes (Fig. 3A). For example, genes that
were downregulated by subtype B but were upregulated by
subtypes C and A/E (shown in cluster 1) included the IFN
inducible gene STAT1, the tumor suppressor and MAPK1/
ERK2 kinase regulator ST5, and the tyrosine phosphatase
PTPLA, CXCL3, MGMT, and SHC1. Genes stimulated by
clade B and downregulated by clades C and A/E (cluster 2)
included the inhibitor of matrix metalloproteinase TIMP2, the
PTP family member PTPRM and the heat shock protein 40
homolog (Hsp40) DNAJB1, which was shown to enhanceNef-mediated viral gene expression and replication by
interacting with the Nef HIV-1 protein (Kumar and Mitra,
2005). In Fig. 3B, PCA analysis demonstrated clearly the
distribution of the 3 subtypes across the 3 principle
components of the genes, where 1 principle separated subtypes
C and A/E from subtype B, again implying that subtypes C
and A/E triggered a similar host response against viral
infection compared to subtype B. The subset of genes
discriminating the HIV-1 clades was not statistically strong
enough to distinguish a clade-specific gene signature. Since
more subtle differences between the clades were most likely
masked by patient variability among the four donors, we
cannot propose a distinct clade-specific gene signature in DCs.
Based on this preliminary analysis, we were able to measure
the activation or repression of several genes that distinguished
Fig. 2. Kinetics of DC infection by HIV-1 clades B, C, and A/E. DCs were
obtained from peripheral blood of healthy donors after culture of monocytes for
6 days in medium supplemented with IL-4 and GM-CSF. Cells were exposed for
2 h at 37 °C to an MOI of 0.1 of HIV-1 clades B, C, and A/E and washed twice
with PBS to remove unbound virus. Supernatants from HIV-infected or
uninfected DC were harvested 2, 6, 24, and 72 h after the infection. The presence
of p24 Gag antigen was detected by ELISA from serial dilutions of supernatants;
the data are corrected for supernatant dilutions obtained with donors #152 and
#160. ● = Subtype B; ■ = subtype C; ▴ = subtype A/E.
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Further characterization of HIV-1 infection of DCs may reveal
additional gene signatures that differentiate clade-specific
expression profiles.
Classification of HIV-1-modulated genes into functional
groups
Because only minor differences in gene expression
between clades were observed, subsequent analysis was
performed on the basis of infection and time, regardless of
the subtype. With this perspective, 3700 genes were
subjected to a significance analysis of microarrays (SAM).
For each time point, genes that were significantly induced or
that were repressed during HIV-1 infection were selected
with an estimated false discovery rate (FDR) of 4–9% when
a Δ = 0.4–0.6 was used as a threshold. A total of 656 genes
were selected as significant at 2, 6, 24, and 72 h,
respectively, and were further divided into 8 functional
categories using NCBI, DAVID, and BioRag databases. Re-
gardless of the time of infection, 20% (127 out 656) of the
genes affected by HIV-1 were involved in signal transduc-
tion, followed by 14% (117 out of 656) of the genes,
identified as transcription-related genes, and 7% (49 out of
656) were classified as playing a role in cell proliferation
and cell cycle (Fig. 4). Furthermore, 7% (45 out of 656) of
the genes were immune response genes. Relatively low
representation was found in the functional categories of
apoptosis (2%), receptor activity (5%), or cytokine/chemo-
kine activity (1%).
The expression pattern of the different functional groups
varied with time after HIV-1 infection. During the immediate
and early phase (2 and 6 h postinfection), most of the
regulated genes were associated with transcription, signal
transduction, receptor activity, and cell proliferation/cell
cycle. Immune-responsive genes and cytokine/chemokinegenes also appeared to be modulated early after infection,
followed by a decrease at later times. Unexpectedly, at 24
h postinfection no major changes in gene regulation were
observed for any of the functional groups, although gene
activity resumed after 24 h. Unaltered gene expression at 24
h may be due to the low number of donors obtained that
rendered the analysis difficult. Even though very few genes
fall into the apoptosis category, regulation of apoptosis was
mainly observed at 72 h, indicating that dendritic cells might
be dying due to infection associated with prolonged in vitro
culture.
Immediate and early genes affected by HIV-1 infection in
iMDDC
As early as 2 h postinfection, many gene alterations were
observed and selected on the basis of a P value less than
0.05 from the ANOVA (Fig. 5). Due to some variations in
the response between the donors, the gene expression values
for the individual genes were described as a range of fold
change for all 4 donors, with the fold change between 2 and
4. Gene profiles at 2 h postinfection were different from the
profiles observed at 6 h (Fig. 6). Several signal transduction
genes were highly activated at both times; for example,
TIMM44, BMP7, CLCN6, and CRKL (adaptor protein
member of the CRK family), the serine/threonine-type
protein kinase CLK3, and MAP3K2 (member of the
mitogen-activated protein kinase kinase kinase family) were
upregulated at 2 h postinfection (Fig. 5B). PLAUR
(urokinase-type plasminogen activator receptor), MAP3K11
and MAP3K14, and the cAMP-dependent protein kinase
PRKAR1 were upregulated at 6 h postinfection (Fig. 6B and
Supplementary Table 1), respectively. CRKL is known to
participate in the Ras and Jun kinase signaling pathways and
in IFN-mediated signaling through the interaction of TYK2
(Ahmad et al., 1997). Upregulation of MAP3K2, MAP3K11,
and MAP3K14 suggests an activation of the MAPK pathway
as well.
Many transcription factor genes were altered at 2 and 6
h postinfection; an important component of the NF-κB sig-
naling cascade, NFKB1 (p105), was upregulated at 2
h postinfection. NFKB1 has a well-characterized role in
transcriptional activation of the HIV-1 LTR (Alcami et al.,
1995; Demarchi et al., 1996) and also in the expression of
many cytokines including IL-2, IL-6, IL-8, and IL-10 (Ehret
et al., 2001; Mahieux et al., 2001; Badou et al., 2000; Scala et
al., 1994). Transcription factors TFEB (transcription factor
EB), the cell growth suppressor HOXB13, ELF1, LMO1, and
GTF2H1 (general transcription factor IIH) were strongly
upregulated at 6 h postinfection. Genes involved in the basal
transcriptional machinery were highly elevated at both 2 and
6 h postinfection, including TAF6L (p300/CBP-associated
factor TAF6-like RNA polymerase II) and SURB7 (RNA
polymerase II holoenzyme component; Bres et al., 2002;
Cujec et al., 1997). In addition, downregulation of some
genes involved in transcriptional regulation was observed.
HDAC2, PBX1, TBL1X, TFAP2C (transcription factor AP-2
Fig. 3. ANOVA of HIV-1 infection at 72 h postinfection. ImmatureMDDCs from four healthy donors were infected or not with subtype B, C, or A/E at anMOI of 0.1 for 2, 6,
24, and 72 h. RNAwas extracted from cells harvested at each time point for the infected and uninfected samples and subjected to microarray analysis. ANOVA analysis was
performed on 3700 genes that showdifferential expressionwith respect to subtypes and 65 geneswere selected (P<0.05). Ratioswere expressed in terms of uninfected samples.
Log2 ratios are depicted in green (downregulated) or red (upregulated). The magnitude of the regulation is illustrated by the intensity of the color. Genes were clustered into 2
basic groups. Cluster 1 is composed of genes upregulated inHIV-1 subtypesC andA/E and dowregulated inHIV-1 subtypeB. Cluster 2 consisted of genes upregulated byHIV-
1 subtype B and downregulated by HIV-1 subtypes C and A/E. (B) 3D plot of the first 3 principle components of the genes depicted in panel A showing subtypes distribution.
(For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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(TAR DNA binding protein) were repressed at 2 and 6
h postinfection (van 't Wout et al., 2003; Duan et al., 1994;
Kamine and Chinnadurai, 1992; Wang et al., 1995).
Genes with a role in cell proliferation, cell cycle, and
apoptosis were altered at 2 and 6 h postinfection (Figs. 5 and
6); VGFC, RABGAP, HSPA2, and PPP2R2C (PP2A regula-
tory subunit B) were increased at 2 h postinfection. HSPA2 is
known to interact with HIV-1 Gag to facilitate nuclear import
of the viral preintegration complex (Agostini et al., 2000).
Previous studies demonstrated the role of PP2A in the
modulation of HIV-1 gene expression through the interaction
with Tat (Ruediger et al., 1997) and Vpr, which is known toinduce cell cycle G2 arrest through a pathway involving the
regulatory and catalytic subunits of PP2A (Elder et al., 2001,
2002; Goh et al., 1998).
Lastly, genes playing an important role in the induction of
the host immune response through the modulation of
different signaling pathways were upregulated in HIV-1-
infected iMDDC, at 2 and 6 h postinfection (Figs. 5 and 6).
At 2 h, inflammatory cytokines and cytokines receptors
(such as IL-6, IL1B, IRF-5, IL2RA, IL1RL1, and IL1R2)
were upregulated, whereas upregulation of IRF-1, IFN-γ,
IFN-stimulated genes (IFIT2, IFIT5), and cytokine/chemo-
kine-related genes (IL-1A, IL1-RAP, IL-10RA, CRLF3, CKLF,
and CCL2/MCP-1) was observed at 6 h. In conclusion, the
Fig. 4. Functional categories of genes modulated by HIV-1 infection. Immature
MDDCs from four healthy donors were infected or not with subtype B, C, or A/E
at an MOI of 0.1 for different times. RNAwas extracted from cells harvested at
each time point for the infected and uninfected samples and subjected to
microarray analysis. A SAM analysis was performed on 3700 genes in which
changes in gene expression were obtained by normalizing the values of the HIV-
1-infected MDDCs against the noninfected MDDCs. A set of 656 genes was
selected as being significantly altered by HIV-1 regardless of the time points and
subtypes. A total of 8 functional categories were assigned and obtained through
search tools NCBI and DAVID. The total number of genes within each functional
category including all time points (i.e., 2, 6, 24, and 72 h postinfection) is
represented by the pie chart.
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virus entry triggered genes from different signaling pathways
including different kinases that activate key components of the
transcription machinery. At 6 h postinfection, the HIV-1
further stimulated the host cellular machinery, hence allowing
a progressive viral expansion in targeted cells. The early de-
tection of virus was accompanied by an immune activation of
DCs.
Late genes affected by HIV-1 infection in iMDDC (24 and 72 h)
We next investigated gene expression at 24 and 72
h postinfection (Figs. 6C and 7). At 24 h, HIV-1 replicative
cycle reached a plateau and was sustained up to 72 h.
Interestingly, few genes were transiently altered at 24
h postinfection and most of them were upregulated (Fig.
6C). In the upregulated group of genes, the principal targeted
genes were kinases belonging to the MAPK signaling
pathway such as MAP3K5, MAPK10, and MAPKAPK3 and
other kinases signaling through different pathways such as
the p21 (CDKN1A)-activated kinase PAK6, the AKT/PI3K
signaling kinase PIK3R1 (important in cell survival), and the
protein kinase C.
A resurgence of gene expression was observed at 72 h, at
a stage of HIV-1 infection where gene expression appeared
to be significantly altered, with approximately equal
numbers of upregulated and downregulated genes (Fig. 7
and Supplementary Table 2). First, HIV-1 infection differ-
entially modified the expression level of two calcium/
calmodulin-dependent protein kinases CAMK2D and
CAMK1. CAMK1 was strongly upregulated, and CAMK2D
was downregulated, as previously described (Izmailova etal., 2003). On the other hand, CAMKII is a component of
the MAPK pathway and is activated by PLC. Another
downregulated kinase was PAK1 (p21/Cdc42/Rac1-activated
kinase; Fig. 7A), which signals through several pathways
including the MAPK pathway and Fas signaling pathway
(Wu et al., 2004).
Upregulation of transcription factors such as RELA was
detected at 72 h, indicating the activation of the NF-κB
pathway (Fig. 7B). Overall however, genes involved in
regulation of the transcriptional apparatus were mainly
decreased. Among transcription factors affected by HIV-1
were TBP, GTF2F2, SP2 and the transcription regulator
SUPT5H (Bourgeois et al., 2002; Ping and Rana, 2001). Late
after infection, some pro-apoptotic genes that were initially
detected at 24 h were also upregulated, including the TNF
receptors TNFRSF17, TNFRSF10 and TRAF1.
Finally, RQ-PCR analysis was performed to confirm
differential expression of selected genes observed in the
microarray study. Genes validated with three different donors
included: TBP, Casp8, IFIT5, IL10RA, LILRB1, STAT1,
RelA, ST5, TIMP2 and PTPRM, as shown in Table 1 or
Supplementary Table 3. Four out of five genes (IFIT5,
IL10RA, Casp8, RelA) validate with respect to the
individual donors where the P values were calculated for
each donor. Due to donor variability it was more useful to
examine individual donors; nevertheless, the mean values of
genes at 6 and 72 h are also shown with the P values,
regardless of donor (Table 1). TBP was the only gene that
did not validate and was generally upregulated among the
donors according to the RQ-PCR results and downregulated
in the microarray. The RQ-PCR validation of the MDDC
infection with clade-specific viruses is shown in Supple-
mentary Table 3 and the results are consistent with the
microarray results. As described above, any clade-specific
signature is masked by the variability among the small
number of available samples.
In conclusion, gene expression profiling has demonstrated
that HIV-1 infection alters DC gene expression in a time-
dependent manner, regardless of HIV-1 subtype or donor spe-
cificity. Early after infection (2 and 6 h), genes involved in
signaling pathways – kinases and transcriptional proteins –
along with immune response genes were induced, whereas
during later stages of infection (24 and 72 h), genes involved in
signaling pathways and apoptosis were modulated by HIV-1
infection of DC.
Discussion
In this study, we sought to examine the differences in gene
expression profiles induced by primary isolates of HIV-1
clade-specific viruses—subtypes B, C and A/E in immature
monocyte-derived dendritic cells. For the purpose of this
study, focus was placed on the analysis of a single isolate
representing a particular subtype rather than examining
specific variations among several isolates, due to the
availability of donors. In fact, several other donors had to be
excluded from this study when it was determined that some
Fig. 5. Gene expression profiling of the immediate phase (2 h) of HIV-1 infection in DCs. A SAM analysis on samples of immature MDDCs infected with HIV-1 was
performed as described in Materials and methods. A set of 101 genes was selected as repressed or activated (between a 2-fold and a 4-fold change) by HIV-1 at
2 h postinfection. Genes depicted in green (A) or red (B), respectively, were further divided into 8 functional categories. 
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skewed the transcriptional profiling. Microarray studies have
evaluated the gene expression profiles elicited by HIV-1 in
different cell models such as macrophages (Vazquez et al.,
2005; Woelk et al., 2004), T cells (Bosinger et al., 2004; van 't
Wout et al., 2003; Krishnan and Zeichner, 2004; Geiss et al.,2000) and immature DCs (Izmailova et al., 2003), using
primarily HIV-1 subtype B and mostly laboratory-adapted
strains. In the present study, HIV-1 subtype B resulted in a
more robust infection of DC than either HIV-1 clade C or A/E,
perhaps due to increased viral replication in DC or more
efficient viral binding and entry with subtype B. Although the
Fig. 6. Gene expression pattern representing the early phase (6 and 24 h) of HIV-1 infection in immature MDDCs. A SAM analysis on samples of immature MDDCs
infected with HIV-1 was performed as described in Materials and methods. A set of 121 genes was selected as repressed or activated (between a 2-fold and a 4-fold
change) by HIV-1 at 6 h and 42 genes at 24 h postinfection. Downregulated and upregulated genes are depicted in green or red, respectively, and were further divided
into 8 functional categories. Panels A and B show genes regulated at 6 h, whereas panel C shows genes altered at 24 h postinfection.
93M. Solis et al. / Virology 352 (2006) 86–99HIV-1 clades exhibit extensive genomic diversity, the gene
expression profiles elicited by the different clades in DCs were
not sufficiently distinct to distinguish a clade-specific gene
signature.
Some expression variations were detected at 72 h postinfec-
tion that did distinguish among the clades; the IFN-inducible
Stat1, CXCL3 and SHC1, were upregulated by clades C and
A/E, whereas the inhibitor of the matrix metalloproteinaseTIMP2 and the heat shock protein 40 homolog (Hsp40)
DNAJB1 were upregulated only by clade B. Perhaps these
differences are due to viral infection efficiency or to the quantity
of virus present. Further analysis of the differences in gene ex-
pression between the subtypes at later times after infection may
also reveal stronger patterns of differential expression.
Dendritic cells are one of the initial targets for HIV-1 infection
after crossing the mucosal barrier at the site of transmission (Lore
Fig. 7. Gene expression pattern in the late phase (72 h) of HIV-1 infection in immature MDDCs. A SAM analysis on samples of immature MDDCs infected with HIV-1
or not was performed as described in Materials and methods. A set of 92 genes was selected as repressed or activated (between a 2-fold and a 4-fold change) by HIV-1
at 72 h postinfection. Downregulated and upregulated genes are depicted in green (A) or red (B), respectively, and were further divided into 8 functional categories.
(For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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takes advantage of the DC to escape immune surveillance is still
not well understood. Studies have elucidated the pathway by
which the DC captures, concentrates, and then releases virions at
replication-competent sites in lymphoid tissue. However, whether
the DC is efficiently infected in the process is still a debate.
Several reports have suggested that the state of DC activation asobserved by the expression levels of the receptors and coreceptors
such as CD4, CCR5, CXCR4, respectively, and the C-type lectin
receptor DC-SIGN (CD209) determine whether DCs are
productively infected by HIV-1 (cis-infection) or whether DCs
only capture and internalize virus while transferring infectious
virions to CD4+ T cells (trans-infection), without being directly
infected (Lee et al., 2001; Rinaldo and Piazza, 2004; Turville et
Table 1
Microarray results were validated against the RTPCR in log2 units, as detailed in
Materials and methods
Time IFIT5 IL10RA Time CASP8 RELA Donor
Mean
array
6 −0.12 0.50 72 −0.45 0.65 140
6 0.57 0.37 72 −0.02 −0.03 152
6 0.48 0.72 72 −0.03 0.88 160
Mean
PCR
6 −1.10 0.47 72 0.69 1.03 140
6 0.42 0.86 72 −0.01 −0.16 152
6 0.27 0.02 72 −0.71 0.96 160
P value 6 0.573 0.978 72 0.138 0.492 140
6 0.731 0.605 72 0.882 0.526 152
6 0.710 0.229 72 0.237 0.926 160
Mean
array
6 0.310 0.527 Mean
Array
−0.166 0.519
Mean
RT-PCR
6 −0.137 0.453 Mean
RT-PCR
−0.007 0.609
P value 6 0.424 0.848 P value 0.588 0.807
The calculations were performed by normalizing to the GAPDH and the
noninfected samples given by: ddCT = dCT(Sample) − dCT(noninfected),
where dCT(Sample) = CT(Sample) − CT(GAPDH) and dCT(noninfected) = CT
(noninfected) − CT(GAPDH). The P values were calculated using a two-
tailed t test, and assuming that the variances were unknown.
95M. Solis et al. / Virology 352 (2006) 86–99al., 2003). High levels of CCR5 on immature DCs in particular
favor cis-infection, whereas higher expression of DC-SIGN
(CD209) predicts trans-infection (Pope et al., 1995).
Several reports suggest that R5-tropic, but not X4-tropic HIV-
1, replicates actively in immature DCs (Patterson et al., 1991;
Langhoff et al., 1993; Tsunetsugu-Yokota et al., 1995), whereas
others have shown a relatively low level of replication in mature
DCs in vitro (Pope et al., 1995). Differences in infectivity may be
explained by the differences in CCR5 levels, which are higher in
immature DCs than in mature DCs. However, extensive virus
replication was observed when DCs were exposed to HIV-1 and
then cocultured with CD4+ T cells. In the present study, our
immaturemonocyte-derived DCs expressed both CCR5 andDC-
SIGN and HIV-1 replication was observed shortly after infection
at 6 h and continued up to 72 h postinfection, suggesting efficient
viral infection and replication (Fig. 2). Maturation of immature
DCs by HIV-1 infection remains controversial. Although early
release of cytokines/chemokines such as IL-15, CCL2/MCP-1,
IL-6, and IL-1 was observed in the present study, we did not
observe a dramatic increase in surface expression of maturation
markers such as CD40 (data not shown) and CD80 (Fig. 1).
In summary, the encounter between DCs and HIV-1 elicited a
strong host cellular response that was observed through the
modulation of several functional categories of genes at different
times after HIV-1 infection. Binding of the virus triggered an
early response characterized by a gene expression profile at 2
h postinfection that reflected the activation of signaling
pathways and transcription factors (Fig. 5). At 6 h postinfection,
HIV-1 replication further upregulated signal transduction,
transcription, and kinase-related genes, in particular the NF-
κB, MAPK, and Ras/Jun signaling pathways, leading to the
activation of a host inflammatory response involving upregula-
tion of cytokine (IL-1α/β, IL-6) genes and genes of the IL-1/TLR pathways such as IL2RA, IL1RL1, IL1-RAP, and IL1R2
(Fig. 6). Conversely, HIV-1 regulatory proteins such as Tat, Nef,
and Vpu impair different aspects of the host response, such as the
antigen presenting function of DC and the surface expression of
MHC class II (Kanazawa et al., 2000) and MHC class I (Collins
and Baltimore, 1999; Kamp et al., 2000; Kerkau et al., 1997) and
may actually interfere with the full development of the immune
response to infection. Understanding the variability of the
immune response triggered by HIV-1 subtypes will lead to the
development of more efficacious vaccines and enhance our
knowledge of the different mechanisms used by HIV-1 subtypes
to evade the innate immune response in DCs.
Materials and methods
HIV-1 isolates
HIV-1 B and C primary isolates were provided by the McGill
AIDS Centre and were isolated from treatment-naive HIV-1-
infected patients fromMontreal and Ethiopia, respectively (5264,
4761). The HIV-1 A/E primary isolate was provided by the NIH
AID Research and Reference Reagent Program, Division of
AIDS, NIAID, and NIH (Rockville, Maryland, USA). All three
viruses were R5-tropic strains. Propagation of primary HIV-1
isolates was performed in peripheral blood mononuclear cells
(PBMCs) according to the protocol provided by SRA Life
Sciences, NIH AID Research and Reference Reagent Program,
Division of AIDS, NIAID, NIH. To purify virus from medium,
the viral particles were pelleted by ultracentrifugation at 40,000
rpm for 1 h on to a sucrose cushion using a Beckman SW-40
rotor. Virus infectivity was determined by functional assay of
50% tissue culture infective dose/ml (TCID50/ml).
Reagents
Recombinant human IL-4 was purchased from Sigma (St.
Louis, MO) and recombinant human GM-CSF was a gift from
Biosource International (Camarillo, CA). PE-conjugated antibodies
specific for CD14, HLA-DR, CD1a, CD80, CD83, CCR5, DC-
SIGN, and CD3, APC-conjugated antibody specific for CD4, PE-,
orAPC-conjugated isotype antibodies controlwere purchased from
Beckton-Dickinson (Sunnyvale, CA), and anti-CD14-conjugated
microbeads were purchased from Miltenyi Biotec (Auburn, CA).
Human serumABwas purchased fromGem-Cell (Woodland, CA).
The Rosette Sep CD3+ cell depletion cocktail was obtained from
Stem Cell Technologies Inc. (Vancouver, Canada). The anti-HIV-1
p24 ELISA kit Vironostika HIV-1 antigen was purchased from
Biomerieux Canada (St. Laurent, QC, Canada). As a phenotypic
control for maturation ofMDDC,MDDCwere activated with LPS
from Escherichia coli 026:B6 (Sigma, St. Louis, MO).
In vitro differentiation of monocyte-derived dendritic cells
(MDDC)
Peripheral blood mononuclear cells (PBMC)were isolated by
density centrifugation on Ficoll-Paque Plus (Amersham Bios-
ciences, Uppsala, Sweden) from fresh apheresis obtained with
96 M. Solis et al. / Virology 352 (2006) 86–99informed consent from healthy donors. CD3+ cells were re-
moved from whole blood using CD3+ cell depletion cocktail
(StemCell Technologies).Monocytes were isolated from PBMC
by magnetic cell sorting using anti-CD14-conjugated microbe-
ads (Miltenyi Biotec). The purity of the CD14+ monocyte
population was assessed by flow cytometry and was typically
98% or greater in the absence of any contaminating CD3+ cells.
Monocytes were cultured for 6 days in RPMI 1640 supplemen-
ted with 1% human serum AB, 300 U/ml IL-4, 1000 U/ml GM-
CSF, 2 mM L-glutamine, 10 mM HEPES, nonessential MEM,
penicillin, and streptomycin. The cells were fed with IL-4 and
GM-CSF on days 2 and 4, and immature MDDC were collected
on day 6 and cell differentiation was monitored by flow cyto-
metry for CD14, HLA-DR, CD1a, CD83, CD80, CCR5, CD4,
and DC-SIGN.
Infection of MDDC
MDDCs were infected in pellet for 2 h at an MOI of 0.1 and
washed twice with PBS to remove unbound viral particles. Cells
were then plated in RPMI 1640, supplemented as described
above. Supernatants and cells were harvested at 2, 6, 24, and
72 h after infection for p24 antigen detection and RNA extrac-
tion, respectively.
Microarray experimental design
Microarray analysis was performed on 4 donors, representing
a total of 64 samples. A focused immune array was provided by
CANVAC as part of a larger study (Genome Canada/Quebec
project title ‘S2K’), whose purpose was to build a model of
immune response based on viral infection by HIV, HCV, SARS,
and Yellow Fever as well as bone marrow and solid organ
transplantation. The array contained an assortment of genes from
different pathways and functional classes. The larger study
covered approximately 3000 samples to be incorporated into the
modeling and for this reason samples were analyzed through an
indirect design using a universal human RNA probe as a refe-
rence (Stratagene). Samples and the universal RNAwere labeled
with Cy5 and Cy3, respectively. Dye-swap was performed to
investigate the proportion of dye incorporation between Cy3 and
Cy5; no significant differences between the dyes were observed
(data not shown).
RNA isolation, amplification, and hybridization
Total RNAwas extracted from a total of 2 × 105 MDDC per
sample at each time point (2, 6, 24, and 72 h postinfection using
the RNeasy kit; Qiagen, Mississauga, Canada). Total RNAwas
amplified using the MessageAmp mRNA kit (Ambion, Austin,
USA). Sample and universal human RNA probes (Stratagene)
for microarray hybridization were prepared by labeling the
amplified RNAwith Cy5 or Cy3, respectively, by reverse tran-
scription, and hybridizing the labeled cDNA on the CANVAC
(http://www.canvac.ca/) human Immunoarray version 2 manu-
factured by the Microarray Center (UHN, Toronto, ON, Canada)
containing 7256 duplicate spots representing 3628 expressedsequence tags (ESTs). Details of the labeling and hybridization
procedures can be obtained at http://transnet.uhnres.utoronto.ca.
Microarray analysis
Microarrays were scanned using Scanarray Express Scanner
(Packard Biosciences) at 10-μm resolution. QuantArray (Pack-
ard Biosciences) version 3 was used to quantify the scanned
images, producing quantarray output file in text format. Micro-
arrays were analyzed for quality by visual inspection of the array
to flag poor quality spots during scanning, followed by the use of
automated scripts that scanned the quantified output files and
measured overall density distribution on each channel and
number of flagged spots. Each quantified output file was then
run though the following preprocessing using R (http://www.r.
project.org) and Limma (Smyth, 2005). (1) Cy3 and Cy5 signals
were filtered for low signal intensities using a surrogate
replacement policy that replaces values less than or equal to
256 with 257. (2) Merge duplicate probes: for each green (Cy3
Control) and red channel (Cy5 Sample), duplicate spots for each
probe were merged; all probes that exceeded the lower minimal
filter were almost identical. (3) Normalize within arrays: the raw
merged red and green channels were then lowness normalized
(by subgrid) and transformed to log2 ratios. (3) Normalize
between chips: the average brightness of each array was cor-
rected using quantile normalization. (4) Normalize against non-
infected samples: for each time point 2, 6, 24, and 72 h, each
noninfected sample was subtracted from each infected sample.
Analysis and visualization was performed with Genelinker
Platinum 4.5 software (Improved Outcomes Software) and SAM
(Significance Analysis of Microarrays) excel add-in (Tusher et
al., 2001). Analysis of the time course of HIV infection was
performed through the selection of genes with a significance
P < 0.001 in Genelinker using ANOVA modeling early (2 and
6 h) versus late (24 and 72 h) time points. SAM one class
response was performed on samples at each time point sepa-
rately. The analysis of clades at each different time points was
performed through the selection of genes with a significance of
P < 0.05. Annotations on genes were gathered using manual
searches using NCBI and the ontology tool DAVID.
RQ-PCR
Validation of selected target genes was performed by relative
quantification PCR (RQ-PCR). A total of 2 μg of amplified RNA
from uninfected and HIV-1-infected samples was converted to
cDNA using the High Capacity cDNA Archive Kit (Applied
Biosystems, Foster City, CA) according to the manufacturer's
protocol. TaqMan Gene Expression Assays (Applied Biosystems,
Foster City, CA) were then used to analyze gene expression levels
of 10 selected target genes. First, each sample was subjected to
PCR amplification in duplicates, in which 100 ng of cDNA/
reaction was mixed with TaqMan Universal PCR Master Mix
(Applied Biosystems, Foster City, CA) and then amplified using
predesigned primers and probes. The following predesigned
primers and probe sets were used: TBP (Hs00427620_m1);
Casp8 (Hs00277211_m1); IFIT5 (Hs00202721_m1); IL10RA
97M. Solis et al. / Virology 352 (2006) 86–99(Hs00387004_m1); LILRB1 (Hs00429037_m1); STAT1
(Hs00234829_m1); RelA (Hs00153294_m1); ST5
(Hs00373570_m1); TIMP2 (Hs00234278_m1); and PTPRM
(Hs00267809_m1). GAPDH (Hs99999905_m1) was used as an
endogenous control to normalize for variations in the amount of
starting material in each PCR reaction and the uninfected samples
were used as the calibrator controls. Data were then collected using
the AB 7500 Real-Time PCR System (Applied Biosystems, Foster
City, CA) and analyzed using the SDS v1.3.1 Relative Quantifi-
cation Software by the Comparative CT Method.
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